Get the Stockscreener App
2.18
2.83%
0.06
After Hours:
2.08
-0.10
-4.59%
Atai Life Sciences N V Stock (ATAI) Forecast
The Atai Life Sciences N V (ATAI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.9331, representing a +126.29% increase from the current price of $2.18. The highest analyst price target is $5.0931, and the lowest is $4.773.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATAI Price Target
Average 4.284
(+96.51% Upside)
Is Atai Life Sciences N V (ATAI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 65.01 | Neutral |
| STOCH(9,6) | 80.09 | Sell |
| STOCHRSI(14) | 54.63 | Neutral |
| MACD(12,26) | 0.1841 | Buy |
| ADX(14) | 24.55 | Neutral |
| William %R | -27.80 | Neutral |
| CCI(14) | 136.53 | Buy |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.8425
Buy
|
1.9406
Buy
|
| MA20 |
1.6538
Buy
|
1.7658
Buy
|
| MA50 |
1.5529
Buy
|
1.5864
Buy
|
| MA100 |
1.40
Buy
|
1.496
Buy
|
| MA200 |
1.4517
Buy
|
1.4755
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ATAI could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on ATAI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 65.01 indicates that ATAI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 80.09 indicates that ATAI is oversold. This means that ATAI price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 54.63 indicates that ATAI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.55 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 136.53 indicates that ATAI is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ATAI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Atai Life Sciences N V financial reports and earnings history, Atai Life Sciences N V (ATAI) stock could reach $6.1483 by 2030, $54.93 by 2040 and $84.17 by 2050. See the projected annual prices until 2050 of the Atai Life Sciences N V stock below:
- Atai Life Sciences N V (ATAI) is expected to reach an average price of $26.67 in 2035, with a high prediction of $26.45 and a low estimate of $26.58. This indicates an $1,123% rise from the last recorded price of $2.18.
- Atai Life Sciences N V (ATAI) stock is projected to chart a bullish course in 2040, with an average price target of $55.80, representing an $2,460% surge from its current level. The forecast ranges from a conservative $7.0669 to a sky-high $54.93.
- Our analysts predict Atai Life Sciences N V (ATAI) to jump 1,691% by 2045, soaring from $39.14 to an average price of $39.05, potentially reaching $39.87. While $39.14 is the low estimate, the potential upside is significant.
- Atai Life Sciences N V (ATAI) stock is expected to climb by 2050, reaching an average of $82.41, a $3,680% jump from its current level. However, a wide range of estimates exists, with high and low targets of $84.17 and $82.96, respectively, highlighting the market's uncertainty.
Atai Life Sciences N V Stock (ATAI) Year by Year Forecast
Atai Life Sciences N V Stock (ATAI) Price Forecast for 2025
Atai Life Sciences N V Stock (ATAI) is expected to reach an average price of $4.284 in 2025, with a high prediction of $5.1136 and a low estimate of $3.4545. This indicates an +96.51% rise from the last recorded price of $2.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $4.8132 | $4.773 | $5.0931 | +120.79% |
| April, 2025 | $5.2636 | $4.8334 | $5.1136 | +141.45% |
| May, 2025 | $3.9638 | $4.7138 | $4.6486 | +81.83% |
| June, 2025 | $3.6541 | $4.2339 | $4.0041 | +67.62% |
| July, 2025 | $3.3745 | $3.4545 | $3.2458 | +54.79% |
| August, 2025 | $4.1847 | $3.5545 | $3.9447 | +91.96% |
| September, 2025 | $4.255 | $4.2948 | $4.205 | +95.18% |
| October, 2025 | $3.8654 | $4.1654 | $4.1151 | +77.31% |
| November, 2025 | $3.6257 | $3.594 | $3.4957 | +66.31% |
| December, 2025 | $4.516 | $4.0457 | $4.6159 | +107.16% |
Atai Life Sciences N V Stock (ATAI) Price Forecast for 2026
The predicted value for Atai Life Sciences N V (ATAI) in 2026 is set at an average of $3.3857. Estimates vary from a peak of $4.4967 to a trough of $2.2746, indicating an +55.31% surge from the present price of $2.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.4263 | $4.4563 | $4.4261 | +103.04% |
| February, 2026 | $4.3766 | $4.4061 | $4.2965 | +100.76% |
| March, 2026 | $3.8868 | $4.4288 | $4.4967 | +78.30% |
| April, 2026 | $3.3872 | $3.5322 | $3.6869 | +55.38% |
| May, 2026 | $3.3675 | $3.4175 | $3.2775 | +54.47% |
| June, 2026 | $3.3677 | $3.2527 | $3.3025 | +54.48% |
| July, 2026 | $2.5581 | $2.658 | $3.1078 | +17.34% |
| August, 2026 | $2.7984 | $2.5382 | $2.6284 | +28.37% |
| September, 2026 | $2.6287 | $2.6787 | $2.6485 | +20.58% |
| October, 2026 | $2.559 | $2.609 | $2.6189 | +17.39% |
| November, 2026 | $2.2793 | $2.4293 | $2.4291 | +4.55% |
| December, 2026 | $2.1796 | $2.2746 | $2.2645 | -0.02% |
Atai Life Sciences N V Stock (ATAI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Atai Life Sciences N V (ATAI) is $7.0562, with a high forecast of $14.09 and a low forecast of $0.0187. This indicates an +223.68% increase from the last price of $2.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6499 | $1.7199 | $2.0197 | -24.32% |
| February, 2027 | $1.1002 | $1.1702 | $1.225 | -49.53% |
| March, 2027 | $0.6905 | $0.7055 | $0.8503 | -68.32% |
| April, 2027 | $0.5108 | $0.4407 | $0.3807 | -76.57% |
| May, 2027 | $0.2589 | $0.1789 | $0.749 | -88.12% |
| June, 2027 | $9.52 | $0.0187 | $8.6538 | +336.70% |
| July, 2027 | $5.5006 | $6.1506 | $7.0801 | +152.32% |
| August, 2027 | $7.3711 | $6.4007 | $6.0311 | +238.12% |
| September, 2027 | $6.9918 | $8.0868 | $8.3215 | +220.73% |
| October, 2027 | $9.9124 | $6.962 | $8.8324 | +354.70% |
| November, 2027 | $12.63 | $10.49 | $9.5825 | +479.49% |
| December, 2027 | $14.76 | $13.15 | $14.09 | +577.23% |
Atai Life Sciences N V Stock (ATAI) Price Forecast for 2028
In 2028, Atai Life Sciences N V (ATAI) is projected to reach an average price of $12.67, with a high projection of $14.50 and a low estimate of $10.84. This indicates an +481.30% rise from the last price of $2.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $14.00 | $14.55 | $14.50 | +542.39% |
| February, 2028 | $13.94 | $13.78 | $13.41 | +539.67% |
| March, 2028 | $13.15 | $13.42 | $13.37 | +503.00% |
| April, 2028 | $13.70 | $13.35 | $12.99 | +528.26% |
| May, 2028 | $13.41 | $13.53 | $13.97 | +514.99% |
| June, 2028 | $13.12 | $13.63 | $13.63 | +501.71% |
| July, 2028 | $12.18 | $12.45 | $12.98 | +458.62% |
| August, 2028 | $11.31 | $11.41 | $12.10 | +418.74% |
| September, 2028 | $11.00 | $11.19 | $10.98 | +404.54% |
| October, 2028 | $11.50 | $11.44 | $11.44 | +427.51% |
| November, 2028 | $11.26 | $11.33 | $11.52 | +416.53% |
| December, 2028 | $10.26 | $10.84 | $11.11 | +370.68% |
Atai Life Sciences N V Stock (ATAI) Price Forecast for 2029
The 2029 price forecast for Atai Life Sciences N V Stock (ATAI) is $8.715 on average, with a high prediction of $11.09 and a low estimate of $6.3381. This represents an +299.77% increase from the previous price of $2.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.53 | $10.43 | $10.53 | +383.10% |
| February, 2029 | $10.92 | $10.94 | $11.09 | +401.02% |
| March, 2029 | $10.34 | $10.52 | $10.72 | +374.44% |
| April, 2029 | $10.42 | $10.36 | $10.29 | +378.13% |
| May, 2029 | $9.274 | $9.504 | $10.31 | +325.41% |
| June, 2029 | $8.7745 | $8.7795 | $8.7841 | +302.50% |
| July, 2029 | $8.4351 | $8.5051 | $8.4797 | +286.93% |
| August, 2029 | $7.5558 | $7.8658 | $8.1752 | +246.60% |
| September, 2029 | $7.0263 | $7.0963 | $7.0974 | +222.31% |
| October, 2029 | $6.987 | $6.997 | $7.0068 | +220.51% |
| November, 2029 | $6.7276 | $6.7574 | $6.8272 | +208.60% |
| December, 2029 | $6.2581 | $6.3381 | $6.5777 | +187.07% |
Atai Life Sciences N V Stock (ATAI) Price Forecast for 2030
Atai Life Sciences N V Stock (ATAI) is expected to reach an average price of $10.94 in 2030, with a high forecast of $20.22 and a low forecast of $1.6628. This signifies an +401.99% surge from the last price of $2.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.8488 | $5.8888 | $6.1483 | +168.30% |
| February, 2030 | $5.2694 | $5.3794 | $5.684 | +141.72% |
| March, 2030 | $4.36 | $4.605 | $5.0295 | +100.00% |
| April, 2030 | $3.7405 | $3.8505 | $3.7702 | +71.58% |
| May, 2030 | $2.9812 | $3.1112 | $3.5507 | +36.75% |
| June, 2030 | $2.8118 | $2.7815 | $2.6518 | +28.98% |
| July, 2030 | $1.9125 | $1.8622 | $2.2819 | -12.27% |
| August, 2030 | $19.69 | $1.6628 | $20.22 | +803.22% |
| September, 2030 | $17.35 | $17.48 | $17.48 | +695.92% |
| October, 2030 | $20.35 | $18.07 | $18.93 | +833.58% |
| November, 2030 | $15.01 | $17.69 | $19.23 | +588.67% |
| December, 2030 | $20.49 | $18.21 | $20.07 | +840.08% |
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):